News
Arizona Sonoran Announces Filing of Final Short Form Prospectus in Connection With C$45,000,000 Bought Deal Financing
Arizona Sonoran Copper Company Inc. (TSX:ASCU | OTCQX:ASCUF) (“ASCU” or the “Company”), is pleased to announce that it has filed and been receipted for a final short form prospectus (the
Fuller, Smith & Turner PLC: Transaction in own shares
Funding Circle Holdings plc: HOL-Holdings in Company - AMENDED
AstroNova Sends Letter to Shareholders: Board Focused on Driving Accountability
AstroNova, Inc. (Nasdaq: ALOT), a leading innovator in data visualization technology, today sent the following letter to shareholders:
We urge Shareholders to Vote “FOR” AstroNova’s six highly
Yext Launches Research Program to Power the Future of SEO and Marketing Strategy
Yext, Inc. (NYSE: YEXT), the leading brand visibility platform, today announced the launch of Yext Research. The new initiative is designed to give marketers and SEO professionals access to the
RLJ Lodging Trust Announces Dividends for Second Quarter of 2025
RLJ Lodging Trust (the “Company”) (NYSE: RLJ) today announced that its Board of Trustees has declared a quarterly cash dividend of $0.15 per common share of beneficial interest. The dividend is
Funding Circle Holdings plc: POS-Transaction in Own Shares
LIGHTON: Announcing BioClinical ModernBERT: a new state-of-the-art encoder model for Medical NLP.
Strategic Alliance Between Xlife Sciences AG, JIPYONG LLC and JIPYONG IP to Accelerate Korean Life Sciences Ventures’ Access to Global Capital Markets
Ladder Capital Corp Announces Second Quarter 2025 Dividend to Holders of Class A Common Stock
Ladder Capital Corp (“Ladder” or the “Company”) (NYSE: LADR) today announced the declaration by its board of directors of a second quarter 2025 dividend of $0.23 per share of Class A common stock
Schwab Reports Monthly Activity Highlights
The Charles Schwab Corporation released its Monthly Activity Report today. Company highlights for the month of May 2025 include:
This press release features multimedia. View the full release
R.E.A. Holdings plc: Further re conditional agreement for the sale of CDM
Astria Therapeutics Announces Positive Initial Results from the ALPHA-SOLAR Long-Term Open-Label Trial of Navenibart in Hereditary Angioedema Patients at the European Academy of Allergy and Clinical Immunology Annual Congress
Astria Therapeutics, Inc. (NASDAQ:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic and immunologic diseases, today announced positive initial results
Eurofins Scientific SE: Director/PDMR Shareholding
Eurofins Scientific SE (EUFI.PA) has received various notifications of dealing from Persons Discharging Managerial Responsibilities (“PDMR”). The notification of Dealing Form for each PDMR can be
CI Global Asset Management Announces June 2025 Distributions for the CI ETFs
CI Global Asset Management (“CI GAM”) announces the following regular cash distributions for the month or quarter ending June 30, 2025 in respect of the CI ETFs. In all cases, the distribution will
PROS Holdings, Inc. Announces Virtual Investor Q&A Session and Reaffirms Second Quarter 2025 Guidance
PROS Holdings, Inc. (NYSE: PRO) (“the Company”), a leading provider of AI-powered SaaS pricing and selling solutions, announced that management will host a virtual Q&A session for investors today
Form 8.3 - The Vanguard Group, Inc.: American Axle & Manufacturing Holdings, Inc.
Form 8.3 - The Vanguard Group, Inc.: Unite Group plc, The
Innovative Industrial Properties Declares Second Quarter 2025 Dividends
Innovative Industrial Properties, Inc. (IIP) (NYSE: IIPR), the first and only real estate company on the New York Stock Exchange focused on the regulated U.S. cannabis industry, announced today
Philip Morris International Declares Regular Quarterly Dividend of $1.35 Per Share
Regulatory News:
The Board of Directors of Philip Morris International Inc. (PMI) (NYSE: PM) today declared a regular quarterly dividend of $1.35 per common share, payable on July 15, 2025, to
EQS-Adhoc: APONTIS PHARMA AG: Merger Squeeze-out Cash Compensation Determined at EUR 10.40
MaaT Pharma Presents Updated Positive Data in Early Access Program for Xervyteg® at the EHA Congress Validating High Efficacy Observed in Pivotal ARES Study in Acute Graft-versus-Host Disease
Regulatory News:
MaaT Pharma (EURONEXT: MAAT – the “Company”), a clinical-stage biotechnology company and a leader in the development of Microbiome Ecosystem TherapiesTM (MET) dedicated to
EQS-News: The Platform Group begins entry into the optician industry